Mahoney Stephen F. 4
4 · Viridian Therapeutics, Inc.\DE · Filed Sep 30, 2024
Insider Transaction Report
Form 4
Mahoney Stephen F.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2024-09-27$23.33/sh+21,400$499,262→ 21,400 total
4 · Viridian Therapeutics, Inc.\DE · Filed Sep 30, 2024
Common Stock